Kos Launches $123 Million Fund to Connect Greek Biotech Sector With Global Markets

The investment firm Kos has launched a $123 million fund dedicated to developing connections between international biotechnology markets and the Greek life sciences sector. Founders Simeon Simeonidis and George Tzoukas intend to leverage the Greek scientific diaspora to foster research and commercial partnerships within Southeastern Europe.

The initiative focuses on integrating Greek biotech talent into the broader global ecosystem by establishing formal channels for investment and collaboration. Simeonidis and Tzoukas plan to utilize the $123 million capital pool to support startups and research projects that bridge the gap between local Greek innovation and international industry standards. By tapping into the expertise of Greek scientists working abroad, the firm aims to create a sustainable network that facilitates the transfer of technology and resources into the region.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 18, 2026

Author

GOAI